Search the Newsreel

Sana Biotechnology | SCHEDULE 13G/A: Others

This article is a Schedule 13G/A filing for Sana Biotechnology. It indicates an amendment to a previous filing, typically related to significant ownership of the company's stock by an institutional investor or beneficial owner. This is a standard regulatory disclosure.

ALTINKILIC GIDA VE SUT (ALKLC) Hisse Senedi

Smart Sand : SND

MEGA POLIETILEN Hisse Senedi Canlı Grafik

VAKKO TEKSTIL Hisse Senedi Canlı Grafik

BAREM-AMBALAJ, BARMA Bilanço

SanDisk Has Delivered A Return The Index Cannot, And The Swings That Come With It

Image from Pixabay Its correlation to the market is only moderate, so much of what it does is genuinely its own, but the stock has moved several times as far as the index in both directions. SanDisk (SNDK) is up 21.4% over the last …

Bank of America Issues Pessimistic Forecast for Sana Biotechnology (NASDAQ:SANA) Stock Price

Sandisk Stock Jumps on Its Investor Day Success. Why Wedbush Analysts Aren’t 100% Buying the Story.

SanDisk (SNDK) stock is inching higher on Friday following the flash memory specialist's bullish Investor Day presentation, featuring guidance for mid-to-high teens revenue growth through the end of this decade. Still, Wedbush Securities' senior analyst Matt Bryson recommends some caution, citing lingering skepticism regarding …

Sana Biotechnology (NASDAQ:SANA) Shares Down 5.3% - Should You Sell?

Sana Biotechnology (NASDAQ:SANA) shares dropped 5.3% to $3.4750 on Friday, with trading volume significantly below average. Despite the dip, analyst sentiment is mixed but leans positive, with an average target price of $9.50, although one analyst recently downgraded the stock to "Sell." The company …

Sandisk Stock Soars as JPMorgan Targets $2,250 After Bullish Investor Day

This article first appeared on GuruFocus. Sandisk (NASDAQ:SNDK) shares climbed 6% in premarket trading Friday after new analyst targets followed the company's investor day, where management outlined an ambitious multiyear growth plan. JPMorgan started coverage with an Overweight rating and a $2,250 price target. …

A Top Analyst Says SanDisk Could Buy Back $100 Billion in Stock. If He Is Right, Memory Investors Are Badly Underpricing SNDK Stock

Quick Read Ben Reitzes raised his SNDK price target to $3,600, arguing SanDisk could return $100 billion to shareholders via buybacks over three years. SanDisk's 8 hyperscaler contracts guarantee $93.9 billion in minimum revenue over 4-plus years, signaling memory is shedding its commodity discount. …

Sandisk Stock Tops the S&P 500 Today as Analysts Rally Behind Its AI Expansion

J.P. Morgan resumes coverage of Sandisk stock while Citi doubles down on its bullish call on the heels of the storage provider’s investor day. Continue Reading

Sandisk Just Guided to Turning Half Its Revenue Into Free Cash Flow Through 2030

Memory maker Sandisk (NASDAQ: SNDK) held its investor day on Thursday, and management used it to answer the question hanging over the stock all year: What does this business look like once the boom is no longer a surprise? The company's new financial model …

Las Vegas Sands Corp. stock outperforms market on strong trading day

Shares of Las Vegas Sands Corp. (LVS) advanced by 1.01% to $46.23 on Friday, outperforming a generally down market where the S&P 500 and Dow Jones Industrial Average both saw declines. This marks the second consecutive day of gains for the stock.

BAREM AMBALAJ (BARMA) Hisse Senedi

Earnings Estimates Moving Higher for Sandisk Corporation (SNDK): Time to Buy?

Sandisk Corporation (SNDK) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. The rising trend in estimate …

SpaceX, Sandisk, Micron, Workday, Applied Materials, Reddit, Unusual Machines, and More Stocks That Explain Today’s Market

Sandisk trades higher with several Wall Street firms responding positively to the company’s long-term revenue growth plan. Continue Reading

Sandisk Long-Term Targets Above Estimates, Pricing Model Sustainable, RBC Says

Sandisk's (SNDK) long-term growth and margin targets are above RBC Capital Markets' estimates, while PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …

Why Sandisk Stock Is Soaring Today

Sandisk (NASDAQ: SNDK) stock is surging in Friday's trading, with its stock up 7.1% as of 11:05 a.m. ET. Meanwhile, the S&P 500 was down 0.1%, and the Nasdaq Composite was down 0.3%. Sandisk held an investor day conference yesterday, and the memory technologies …

Solas Capital discloses 7.1% SANUWAVE Health (SNWV) position via managed funds

Solas Capital Management, LLC and its portfolio manager Frederick Tucker Golden have reported a 7.1% beneficial ownership stake in SANUWAVE Health, Inc. (SNWV) through managed funds. This ownership amounts to 610,968 shares, held by two private funds and one sub-advised fund, granting them shared …

Orma Orman Mahsulleri Integre Sanayi ve Ticaret AS (ORMA) Forumu

SanDisk jumps 5% as AlphaSpace chart shows AI storage rally

SanDisk (SNDK) shares rallied alongside memory and storage peers like Micron (MU) and Western Digital (WDC) after unveiling multi-year hyperscaler contracts that signify a shift away from historically volatile memory cycles. Yahoo Finance's Julie Hyman takes a closer look using Yahoo Finance's AlphaSpace. Video …

Is Micron or Sandisk Better Poised For Upside Through The End of September?

Quick Read Micron (MU) leads on HBM AI demand with 84.9% gross margins, while Sandisk (SNDK) jumped 21% after NAND pricing drove 103% sequential data center growth. CEO Sanjay Mehrotra locked in floor gross margins well beyond prior cycle peaks through ~$100B in contracted …

Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.38, Implies 155% Upside

Sana Biotechnology, Inc.'s average 12-month price target has been reduced slightly from $9.5 to $9.38 by 8 analysts, with individual forecasts ranging from $6 to $16 per share. Despite the cut, the new target still suggests a significant 155% potential upside based on the …

Sanepar registra prejuízo de R$ 505,2 milhões no 2T26

MOBILTEL ILETISIM (MOBTL) Hisse Senedi

SABESP Posts Higher Revenue But Lower Profit in Q2 2026 Amid Rising Leverage

Cosan (NYSE: CSAN) to leave NYSE and replace CFO in 2026

Cosan S.A. announced significant corporate restructuring, including the voluntary delisting of its ADSs from the NYSE and a subsequent request for SEC deregistration. The company also detailed a total spin-off of Radar II Propriedades Agrícolas S.A., valued at R$2.57 billion, aimed at simplifying its …

SanDisk Corporation Stock (SNDK) Opened Up by 5.92% on Aug 14: What Signal Does It Send?

DYO BOYA FABRİKALARI SANAYİ VE TİCARET A.Ş.(DYOBY) Sorumluluk Beyanı (Konsolide) 13 Ağustos 2026

ALKIM KAGIT (ALKA) Hisse Senedi

Usana Health Sciences | 10-Q: Q2 2026 Earnings Report

This document is the Q2 2026 Earnings Report (10-Q filing) for Usana Health Sciences. It contains the complete financial and operational disclosures for the second quarter of 2026 as required by regulatory bodies.

BofA Securities Adjusts Sana Biotechnology Price Target to $6 From $7

BofA Securities has lowered its price target for Sana Biotechnology (SANA) to $6 from $7, as reported on August 14, 2026. This adjustment follows other recent news for the company, including its Q2 adjusted loss narrowing and its removal from several Russell Value Benchmarks …

Higher debt and costs pressure Sabesp (NYSE: SBS) Q2 2026 earnings

Sany Heavy Equipment Sets Online Conference on 2026 Interim Results